Rein Therapeutics Inc. has entered into a new financing agreement with Funicular Funds, LP, managed by Cable Car Capital, LP. Under the terms of the securities purchase agreement signed on January 15, 2026, Rein Therapeutics issued and sold an unsecured promissory note with a principal amount of $2,500,000 to Funicular in a private placement. Funicular paid $2,000,000 for the note, reflecting a 20% original issue discount. The note matures on the earlier of the closing of Rein Therapeutics' next capital raise of at least $10 million or June 30, 2026. No interest is payable on the note beyond the original issue discount. The transaction was exempt from SEC registration requirements under Section 4(a)(2) and Rule 506 of Regulation D.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rein Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-015524), on January 16, 2026, and is solely responsible for the information contained therein.